British Journal of Haematology - 138 (3) - Agosto (1ª quinzena)
Images in Haematology
Detection of FIP1L1-PDGFRA fusion by FISH
Edmond S. K. Ma, K. F. Wong, Chris L. P. Wong and Lisa L. P. Siu
p. 279–279
Multisystem Erdheim-Chester disease; a unique presentation with liver and axial skeletal involvement
Arun Gupta, Kholoud Aman, Marwa Al-Babtain, Hanan Al-Wazzan and Rajja Morouf
p. 280–280
Reviews
Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation
Jane Rasaiyaah, Kwee Yong, David R. Katz, Paul Kellam and Benjamin M. Chain
p. 281–290

Modern treatment of thalassaemia intermedia
Caterina Borgna-Pignatti
p. 291–304
Inhibitor development in haemophilia B: an orphan disease in need of attention
Donna DiMichele
p. 305–315
Haematological Malignancy
Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas
M. Ponzoni, F. Berger, C. Chassagne-Clement, M. Tinguely, A. Jouvet, A. J. M. Ferreri, S. Dell'Oro, M. R. Terreni, C. Doglioni, J. Weis, M. Cerati, M. Milani, P. Iuzzolino, T. Motta, A. Carbone, E. Pedrinis, J. Sanchez, J.-Y. Blay, M. Reni , A. Conconi, F. Bertoni, E. Zucca, F. Cavalli and B. Borisch on Behalf of the International Extranodal Lymphoma Study Group (IELSG)
p. 316–323
Aberrant nuclear p53 protein expression detected by immunohistochemistry is associated with hemizygous P53 deletion and poor survival for multiple myeloma
Hong Chang, Joanna Yeung, Connie Qi and Wei Xu
p. 324–329
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
Martin Kropff, Guido Bisping, Elke Schuck, Peter Liebisch, Nicola Lang, Markus Hentrich, Tobias Dechow, Nicolaus Kröger, Hans Salwender, Bernd Metzner, Orhan Sezer, Monika Engelhardt, Hans-Heinrich Wolf, Hermann Einsele, Sarah Volpert, Achim Heinecke, Wolfgang E. Berdel and Joachim Kienast, on behalf of the Deutsche Studiengruppe Multiples Myelom, DSMM
p. 330–337
Activation of Wnt/β-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia
Naveed I. Khan, Kenneth F. Bradstock and Linda J. Bendall
p. 338–348
Distribution of t(14;18)-positive, putative lymphoma precursor cells among B-cell subsets in healthy individuals
Carsten Hirt, Gottfried Dölken, Siegfried Janz and Charles S. Rabkin
p. 349–353
Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation
Naseema Gangat, Jacob Strand, Chin-Yang Li, Wenting Wu, Animesh Pardanani and Ayalew Tefferi
p. 354–358
Platelets, Haemostasis and Thrombosis
Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency
Muriel Giansily-Blaizot, Delphine Thorel, Philippe Khau Van Kien, Catherine Behar, Marie-Catherine Romey, Francine Mugneret, Jean-François Schved and Mireille Claustres
p. 359–365
Thrombin generation: the functional role of alpha-2-macroglobulin and influence of developmental haemostasis
V. Ignjatovic, A. Greenway, R. Summerhayes and P. Monagle
p. 366–368
Haemopoiesis and Leucocytes
Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability
Alice Fabarius, Michelle Giehl, Oliver Frank, Birgit Spiess, Chun Zheng, Martin C. Müller, Christel Weiss, Peter Duesberg, Rüdiger Hehlmann, Andreas Hochhaus and Wolfgang Seifarth
p. 369–373
Red Cells and Iron
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator
Paul Harmatz, Robert W. Grady, Paul Dragsten, Elliott Vichinsky, Patricia Giardina, Jacqueline Madden, Michael Jeng, Becky Miller, Gregory Hanson and Bo Hedlund
p. 374–381
Expression of the γ-globin gene is sustained by the cAMP-dependent pathway in β-thalassaemia
Lakiea Bailey, Yuichi Kuroyanagi, Carla F. Franco-Penteado, Nicola Conran, Fernando F. Costa, Sabrina Ausenda, Maria D. Cappellini and Tohru Ikuta
p. 382–395
Correspondence
Unexpected cardiotoxicity in haematological bortezomib treated patients
Orciuolo Enrico, Buda Gabriele, Cecconi Nadia, Galimberti Sara, Versari Daniele, Cervetti Giulia, Salvetti Antonio, and Petrini Mario
p. 396–397
Hemizygous antithrombin-deficiency (Budapest III) in a newborn presenting with a thrombosis at birth
Søren Risom Kristensen, Marianne Käehne and Niels Erik Petersen
p. 397–398
Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes
Ulrich Germing, Uwe Platzbecker, Aristoteles Giagounidis and Carlo Aul
p. 399–400
Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism
Jose Luís Lobo, David Jiménez, Ma Teresa Orue, Enric Grau, Dolores Naufall, Olga Madridano, Manuel Monreal and the RIETE Investigators
p. 400–403
|